Crossmatch-positive, highly sensitized kidney transplant recipients after desensitization with rituximab ± bortezomib.

被引:0
|
作者
Ide, Kentaro [1 ]
Tahara, Hiroyuki [1 ]
Ohira, Masahiro [1 ]
Nakano, Ryosuke [1 ]
Sakai, Hiroshi [1 ]
Ono, Kosuke [1 ]
Arata, Ryosuke [1 ]
Hakoda, Keishi [1 ]
Imaoka, Koki [1 ]
Fukuhara, Sotaro [1 ]
Bekki, Tomoaki [1 ]
Chogahara, Ichiya [1 ]
Watanabe, Atsuhiro [1 ]
Tanaka, Yuka [1 ]
Ohdan, Hideki [1 ]
机构
[1] Hiroshima Univ, Dept Gastroenterol & Transplant Surg, Hiroshima, Japan
关键词
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
260.9
引用
收藏
页码:122 / 122
页数:1
相关论文
共 50 条
  • [1] Preliminary Outcome of Desensitization With Super High Dose IVIG, Plasmapheresis, and Rituximab for Crossmatch-Positive (Highly Sensitized) Kidney Transplant Recipients
    Omoto, K.
    Furusawa, M.
    Shimizu, T.
    Inui, M.
    Nozaki, T.
    Toki, D.
    Shirakawa, H.
    Ishida, H.
    Tanabe, K.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 451 - 451
  • [2] Preliminary Outcome of Desensitization With Super High Dose IVIG, Plasmapheresis, and Rituximab for Crossmatch-Positive (Highly Sensitized) Kidney Transplant Recipients
    Omoto, K.
    Furusawa, M.
    Shimizu, T.
    Inui, M.
    Nozaki, T.
    Toki, D.
    Shirakawa, H.
    Ishida, H.
    Tanabe, K.
    TRANSPLANTATION, 2014, 98 : 451 - 451
  • [3] Recent Developments in Desensitization of Crossmatch-positive Kidney Transplant Recipients
    Morath, C.
    Opelz, G.
    Zeier, M.
    Suesal, C.
    TRANSPLANTATION PROCEEDINGS, 2012, 44 (06) : 1648 - 1651
  • [4] Imlifidase Desensitization in Crossmatch-positive, Highly Sensitized Kidney Transplant Recipients: Results of an International Phase 2 Trial (Highdes)
    Jordan, Stanley C.
    Legendre, Christophe
    Desai, Niraj M.
    Lorant, Tomas
    Bengtsson, Mats
    Lonze, Bonnie E.
    Vo, Ashley A.
    Runstrom, Anna
    Laxmyr, Lena
    Sjoholm, Kristoffer
    Schiott, Asa
    Sonesson, Elisabeth
    Wood, Kathryn
    Winstedt, Lena
    Kjellman, Christian
    Montgomery, Robert A.
    TRANSPLANTATION, 2021, 105 (08) : 1808 - 1817
  • [5] Desensitization in Crossmatch-positive Kidney Transplant Candidates
    Noble, Johan
    Jouve, Thomas
    Malvezzi, Paolo
    Rostaing, Lionel
    TRANSPLANTATION, 2023, 107 (02) : 351 - 360
  • [6] A Phased Desensitization With Rituximab and Bortezomib for Highly Sensitized Kidney Transplant Candidates
    Ohdan, Hideki
    Ide, Kentaro
    Tanaka, Yuka
    TRANSPLANTATION, 2017, 101 (05) : S12 - S12
  • [7] A Phased Desensitization Protocol With Rituximab and Bortezomib for Highly Sensitized Kidney Transplant Candidates
    Ide, Kentaro
    Tanaka, Yuka
    Sasaki, Yu
    Tahara, Hiroyuki
    Ohira, Masahiro
    Ishiyama, Kohei
    Tashiro, Hirotaka
    Ohdan, Hideki
    TRANSPLANTATION DIRECT, 2015, 1 (05):
  • [8] The Use of Bortezomib for Desensitization in ABO Incompatible and Positive Crossmatch Kidney Transplant Recipients.
    Joseph, J.
    West-Thielke, P. M.
    Thielke, J. J.
    Campbell-Lee, S.
    Vidanovic, V.
    Oberholzer, J.
    Benedetti, E.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2011, 11 : 489 - 489
  • [9] Rituximab in highly sensitized kidney transplant recipients
    Rioveros, Angelito A.
    Munoz, Arlene S.
    Cabanayan-Casasola, Concesa B.
    Danguilan, Romina A.
    Ona, Enrique T.
    NEPHROLOGY, 2008, 13 : A79 - A79
  • [10] Rituximab in highly sensitized kidney transplant recipients
    Munoz, A. S.
    Rioveros, A. A.
    Cabanayan-Casasola, C. B.
    Danguilan, R. A.
    Ona, E. T.
    TRANSPLANTATION PROCEEDINGS, 2008, 40 (07) : 2218 - 2221